3

Inside the numbers, with Jean-pierre Garnier, GlaxoSmithKline CEO and CNBCs Mike Huckman

...GlaxoSmithKline ...earnings to be released today and its possible strategy under chief executive officer-designate Andrew Witty, who will succeed CEO Jean-Pierre Garnier in May. GlaxoSmithKline is ...

Andrew Jack, pharmaceuticals correspondent, on what the appointment of Andrew Witty means for GlaxoSmithKline

CNN's Charles Hodson talks with GlaxoSmithKline CEO Jean-Pierre Garnier about his company's recent drop in earnings.

"It was bad news, almost across the board," Dorman Followwill, healthcare practice director Europe at Frost & Sullivan, said to CNBC's Guy J...